openPR Logo
Press release

Glioblastoma Multiforme Treatment (GBM) Market is exhibiting a positive CAGR of 11.40% by 2022

01-31-2018 12:46 PM CET | Health & Medicine

Press release from: TMR - Research Report

/ PR Agency: TMR - Research Report
Glioblastoma Multiforme Treatment (GBM) Market is exhibiting

Keen players in the global glioblastoma multiforme (GBM) treatment market are striving to maintain their foothold via novel product offerings. These players are focusing hard on the development of newer biological drugs with fewer side effects, which are usually associated with the consumption of immunosuppressants and chemotherapeutic agents.

Collaborations with diagnostic laboratories in order to raise awareness regarding treatment options for glioblastoma multiforme is another key growth strategy adopted by market players to build a strong market presence.

A report by Transparency Market Research projects the global glioblastoma multiforme treatment market will rise at a solid 11.40% CAGR between 2014 and 2022. At this pace, the market is expected to become worth US$0.91 bn by the end of 2022 increasing from US$0.34 bn in 2013.

Read Report Overview: https://www.transparencymarketresearch.com/pipeline-review-of-glioblastoma-treatment-market.html

In this blog post, analysts present answers to some of the pertinent questions regarding developments in the global GBM treatment market:

Q. What are the key factors stoking growth of the global GBM treatment market?

A. The high prevalence of glioblastoma multiforme, which is one of the lethal primary brain tumors among adults is the key factor stoking growth of glioblastoma multiforme treatment market. The inefficacy of the present line of treatment for glioblastoma multiforme to increase the survival rate of patients is necessitating the development of newer treatment modalities. The available treatments are also ineffective to prevent the frequent recurrence of the condition, invasive in nature, and resistance of glioma stem cells for them is leading to an increased demand for novel treatment modalities.

Rising geriatric population globally prone to GBM and involvement of various government and non-government organizations that are raising awareness against GBM is further providing a boost to the global GBM treatment market.

The high resistance of GBM to DNA modifying agents resulting in limitations of available therapies is displaying a desperate need for novel therapeutics. GBM pipeline comprising a mix of small molecules, biological, immunotherapy, and other types of therapeutics is stimulating the development of a novel line of treatment.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4807

Recent advances in molecular biology and gene technology have extended novel treatment possibilities for the treatment of glioblastoma multiforme.

Q. Which are the leading regional markets for glioblastoma multiforme treatment?

A. North America, amongst all, occupies the leading position in the global glioblastoma multiforme treatment market mainly due to the high prevalence of glioblastoma multiforme in the region. In the region, National Brain Tumor Society, the Brain Tumor Foundation of Canada, and the American Brain Tumor Association are some of the bodies that are actively involved in raising awareness regarding GBM. This is aiding the growth of North America market for glioblastoma multiforme treatment.

Q. Which is the key drug in the global GBM treatment market?

A. Among the several treatment modalities for glioblastoma multiforme, temozolomide dominated the global GBM treatment market in 2013. However, the recent loss of patent of the drug has led generic drugs to foray into the market. This has significantly impacted the market share of temozolomide.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glioblastoma Multiforme Treatment (GBM) Market is exhibiting a positive CAGR of 11.40% by 2022 here

News-ID: 924610 • Views: 136

More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is

All 5 Releases


More Releases for GBM

Understanding Impact of COVID-19 on Glioblastoma Multiforme (GBM) Market
Glioblastoma Multiforme (GBM), also known as glioblastoma, is a form of brain cancer. It is a rapidly-growing glioma that develops from star-shaped glial cells, such as oligodendrocytes and astrocytes that support the nerve cells in the brain. GBM is also called as grade IV astrocytoma and is among the most invasive forms of glial tumors. It is a fast-growing and aggressive form of tumor in the central nervous system (CNS)
2019 - 2025 Glioblastoma Multiforme Treatment Market | GBM Market
Global Glioblastoma Multiforme Treatment Market, Its Market Trends And Analysis Glioblastoma multiforme is the high-grade glioma and potent malignant brain tumor that affects glial cells. Glioblastoma multiforme contains the complexly differentiated neoplastic astrocytes which are the subtype of central nervous system. Glioblastoma multiforme is different from the anaplastic astrocytoma due to the presence of hyperplastic blood vessels and necrotic tissue. Request Sample Report: https://precisionbusinessinsights.com/request-sample?product_id=16248 The global glioblastoma multiforme treatment market is
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016
Summary: ReportsWeb.com published “Glioblastoma Multiforme (GBM)” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Original Content: Publisher's clinical trial report, "Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the clinical trials
Glioblastoma Multiforme Treatment (GBM) Industry Analysis by Segments
Glioblastoma multiforme (GBM) is a high-grade gliomas and the most malignant astrocytic tumor, composed of complexly differentiated neoplastic astrocytes, a subtype of central nervous system (CNS). Glioblastoma is clinically classified as grade IV astrocytoma and differs from anaplastic astrocytoma (grade III) due to the presence of necrotic tissue and hyperplastic blood vessels. The diagnosis of GBM is carried out with imaging modules such as computed tomography (CT), magnetic resonance imaging
Glioblastoma Multiforme Treatment (GBM) Market Will Increase Strongly Through 20 …
Glioblastoma multiforme (GBM) is a high-grade gliomas and the most malignant astrocytic tumor, composed of complexly differentiated neoplastic astrocytes, a subtype of central nervous system (CNS). Glioblastoma is clinically classified as grade IV astrocytoma and differs from anaplastic astrocytoma (grade III) due to the presence of necrotic tissue and hyperplastic blood vessels. The diagnosis of GBM is carried out with imaging modules such as computed tomography (CT), magnetic resonance imaging
Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market, 2016 - 2022
Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma and gliosarcoma. Gliomas are tumors arising from glial cells and may occur in the spinal cord or the brain, the latter being more common. Gliomas are the most common type of brain tumor and can be either supratentorial or infratentorial. Seizure,